Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|November 9, 2021
[Laser trials]Nikolaus Hommer, Anton HommerMedicina (Kaunas, Lithuania)|December 23, 2023
An Exploratory Retrospective Data Analysis Comparing the Outcomes of Selective Laser Trabeculoplasty and Argon Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension in Vienna, Austria, from the Year 2012 to 2022Doreen Schmidl, Nikolaus Hommer, Anton HommerActa Ophthalmologica|August 7, 2025
Single oral administration of dronabinol increases ocular blood flow in patients with glaucomaTheresa Lindner, Viktoria Pai, Patrick Janku, et al.Expert Review of Pharmacoeconomics & Outcomes Research|March 1, 2011
Role of fixed combinations in the management of open-angle glaucomaAnton HommerClinical Ophthalmology (Auckland, N.Z.)|June 2, 2011
Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprostAnton Hommer, Friedemann KimmichEuropean Journal of Ophthalmology|November 7, 2015
The status of glaucoma diagnostics and care in Europe in 2015: a European surveyGábor Holló, Anton Hommer, European Journal of Ophthalmology|August 14, 2018
Referral for first glaucoma surgery in Europe, the ReF-GS studyGábor Holló, Doreen Schmidl, Anton HommerJournal of Ophthalmology|October 24, 2015
Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or GlaucomaAnton Hommer, Douglas A Hubatsch, Juan Cano-ParraJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 18, 2014
Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredientsGábor Holló, Anton Hommer, Alfonso Antón López, et al.Current Medical Research and Opinion|June 18, 2010
IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucomaAnton Hommer, Osman Mohammed Ramez, Maria Burchert, et al.Pageof 6